Quantification of tau pathology in the basal forebrain: Associations with age, amyloid, brain structure and cognition

Abstract Background Tau pathology accumulates early in the basal forebrain (BF) in Alzheimer’s disease (AD). The feasibility of measuring in vivo BF tau is unclear given PET resolution and possible partial volume effects of off‐target signal (OTS) which varies by tracer. Method We compared measurements of tau in cognitively unimpaired older adults with either an FTP or MK6240 scan: 93 FTP scans from the Berkeley Aging Cohort Study (BACS), 424 FTP scans from ADNI (N=517 FTP scans; 72.5±7.1 years, 61% F) and 888 MK6240 scans (68.4±5.2 years, 62% F) from the U.S. POINTER imaging study were processed identically to derive SUVRs in native space FreeSurfer regions and template space BF. Using linear regression we explored associations between tau‐PET ROIs across the brain focusing on the temporal lobe (entorhinal cortex [ERC], temporal MetaROI), BF (Ch1‐3, Ch4) and common regions of OTS (e.g., pallidum, thalamus). We examined relationships between tau in these ROIs and age, Aβ, hippocampal volume, BF volume, and cognition. Result The MK6240 cohort was significantly younger, less educated, more racially diverse, and had higher hippocampal and BF Ch1‐3 volume (Table. 1). For both tracers, BF and temporal lobe ROI SUVRs were positively correlated with Aβ, while OTS ROI SUVRs were not related to Aβ (Figure 1). In the BF, the effect size (Cohen’s d) of t‐tests comparing tau SUVR by Aβ status was higher using MK6240 compared to FTP. BF and ERC SUVR positively correlated with age and negatively correlated with hippocampal volume and episodic memory (Figure 2). BF Ch4 SUVR negatively correlated with BF Ch4 volume in both cohorts. Conclusion Evidence that BF tau, along with temporal lobe tau, correlates with Aβ uptake suggests that AD‐relevant tau pathology can be measured in vivo in the BF. In addition, BF tau and temporal tau showed similar relationships to other key variables including age, brain structure and cognition with both tracers. MK6240 slightly better differentiated Aβ positive and negative subjects in BF SUVR measurements compared to FTP. Future research will investigate if BF tau is a critical early marker of AD progression.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.091080
Citations
1
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quantification of tau pathology in the basal forebrain: Associations with age, amyloid, brain structure and cognition

Suzanne L. Baker, Theresa M. Harrison, Tyler J. Ward, William Jagust et al.
1 citations
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
0.39
article

Quantification of tau pathology in the basal forebrain: Associations with age, amyloid, brain structure and cognition

Suzanne L. Baker, Theresa M. Harrison, Tyler J. Ward, William Jagust, Trevor Chadwick, Susan M. Landau
article en
1 citations

Abstract

Abstract Background Tau pathology accumulates early in the basal forebrain (BF) in Alzheimer’s disease (AD). The feasibility of measuring in vivo BF tau is unclear given PET resolution and possible partial volume effects of off‐target signal (OTS) which varies by tracer. Method We compared measurements of tau in cognitively unimpaired older adults with either an FTP or MK6240 scan: 93 FTP scans from the Berkeley Aging Cohort Study (BACS), 424 FTP scans from ADNI (N=517 FTP scans; 72.5±7.1 years, 61% F) and 888 MK6240 scans (68.4±5.2 years, 62% F) from the U.S. POINTER imaging study were processed identically to derive SUVRs in native space FreeSurfer regions and template space BF. Using linear regression we explored associations between tau‐PET ROIs across the brain focusing on the temporal lobe (entorhinal cortex [ERC], temporal MetaROI), BF (Ch1‐3, Ch4) and common regions of OTS (e.g., pallidum, thalamus). We examined relationships between tau in these ROIs and age, Aβ, hippocampal volume, BF volume, and cognition. Result The MK6240 cohort was significantly younger, less educated, more racially diverse, and had higher hippocampal and BF Ch1‐3 volume (Table. 1). For both tracers, BF and temporal lobe ROI SUVRs were positively correlated with Aβ, while OTS ROI SUVRs were not related to Aβ (Figure 1). In the BF, the effect size (Cohen’s d) of t‐tests comparing tau SUVR by Aβ status was higher using MK6240 compared to FTP. BF and ERC SUVR positively correlated with age and negatively correlated with hippocampal volume and episodic memory (Figure 2). BF Ch4 SUVR negatively correlated with BF Ch4 volume in both cohorts. Conclusion Evidence that BF tau, along with temporal lobe tau, correlates with Aβ uptake suggests that AD‐relevant tau pathology can be measured in vivo in the BF. In addition, BF tau and temporal tau showed similar relationships to other key variables including age, brain structure and cognition with both tracers. MK6240 slightly better differentiated Aβ positive and negative subjects in BF SUVR measurements compared to FTP. Future research will investigate if BF tau is a critical early marker of AD progression.

Alzheimer s & DementiaVol. 20(S2)
Lawrence Berkeley National Laboratory (US), University of California, Berkeley (US)
Openalex Percentile: Top 32%
Dementia and Cognitive Impairment Research
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.